Possible Parkinson’s Treatment for Levodopa-Induced Dyskinesia Gets US Patent Protection
Amarantus BioScience Holdings, Inc. (AMBS) received a Notice of Allowance from the U.S. Patent and Trademark Office covering the…
Articles by Ana de Barros, PhD
Parkinson’s Treatment Using Stem Cells to Be Tested in Phase 1/2a Clinical Trial
International Stem Cell Corporation announced that its subsidiary, Cyto Therapeutics, has been given regulatory permission to start a Phase 1/2a dose…
Parkinson’s Disease Biomarkers Are Target of New Research Effort
Researchers at University of California, San Diego School of Medicine, are using a $375,000 grant from the Michael J. Fox…
Parkinson’s Therapy Aims to Get Brain to Produce Beneficial Molecule
In a recent study in the journal PLOS ONE, researchers from the Thomas Jefferson University demonstrate a way…
Parkinson Foundation Helpline Reaches 50,000-Call Milestone
The National Parkinson Foundation (NPF) announced that a proud milestone has been reached: it recently aided the 50,000th caller through its toll-free…
Parkinson’s Diagnosis May Now Be Easier and Earlier
A team of specialists working for the International Parkinson and Movement Disorder Society (MDS) have developed a novel tool for healthcare…
Hours of TV Viewing a Day Can Make You Seriously Ill, US Study Finds
Findings from a recent study published in the American Journal of Preventive Medicine revealed an association between…
Parkinson’s Disease May Leave Telltale Odor on Skin
Parkinson’s UK, the largest charity funder of Parkinson’s research in the U.K., recently launched a new research project that explores the…
ISCO to Present Stem Cell Studies at Neuroscience 2015
California-based biotech, International Stem Cell Corporation (ISCO), will present results of its studies on a novel treatment for Parkinson’s disease during the Neuroscience 2015…
Applications Open For Parkinson’s Disease Foundation’s Research Grants
The Parkinson’s Disease Foundation (PDF) has recently opened applications for its eight grant programs, which will be granted to…